COVID-19 has accelerated adoption of virtual engagement across pharma – but many of these strategies have already been proven over and over again long before the pandemic. The key difference is, what started as a complement to traditional commercialization tactics is now an established best practice and has been core to an inevitable transformation in the pharmaceutical industry. Out of this, the Virtual Sales Organization was born.
Mike Minschwaner, Senior Director and Amy Jamison, Senior Vice President of the Syneos Health Engagement Center discuss the evolution and rationale behind the Virtual Sales Organization, where, when and how it is appropriate to incorporate into sales strategy and the non-traditional skillset required for reps to succeed.
If you want access to more future-focused, actionable insights to help biopharmaceutical companies better execute and succeed in a constantly evolving environment, visit the Syneos Health Insights Hub. The perspectives you’ll find there are driven by dynamic research and crafted by subject matter experts focused on real answers to help guide decision making and investment. You can find it all at insightshub.health.
Like what you’re hearing? Be sure to rate and review us!
We want to hear from you! If there’s a topic you’d like us to cover on a future episode, contact us at [email protected].